scorecardresearch
Add as a preferred source on Google
Sunday, October 12, 2025
TopicCoronavirus vaccine

Topic: coronavirus vaccine

Pfizer-BioNTech Covid vaccine trial on track, CEO says study didn’t stop over safety concerns

Pfizer and BioNTech on track to potentially be the first to show the efficacy of a Covid-19 vaccine, in an environment of intense scrutiny over every possible complication.

Can inhaled vaccines provide better protection against coronavirus? Scientists look for answer

Covid-19 vaccines under development are injectable. Scientists are hoping for better immune responses with inhaled ones that directly target the nose & mouth.

Off The Cuff with Faheem Younus

Dr Faheem Younus, the Chief of Infectious Diseases at the University of Maryland, was the guest at ThePrint's Off the Cuff. Younus talked about...

Expert panel asks Dr Reddy’s to reapply for phase 2, 3 trials of Russian Covid vaccine

According to the CDSCO panel, the pharma company has to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India, a source said.

AstraZeneca resumes Covid-19 vaccine trial in Japan, US still on hold

The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.

Chinese vaccine maker to offer shots first to countries running phase 3 trials

Sinovac, one of three Chinese vaccines in the last stages of testing, is expecting interim data as soon as November from its Phase 3 trial of almost 10,000 people in Brazil.

UK is considering first-ever vaccine trials that expose people to coronavirus

The idea of challenge trials has gained momentum as the pathogen has spread around the world, but such tests exposing healthy people to the coronavirus also raise ethical questions.

Covid vaccine to be widely available in the US by April, CDC chief says

About 700 million vaccine doses should be available by April. The vaccine candidates that are furthest along in development will need a two-dose regimen, CDC chief Redfield said.

Covid vaccines developed outside India might need to undergo clinical trials here, says govt

Guidelines released by the Central Drugs Standard Control Organisation say clinical data generated outside India will be studied to determine the safety & effectiveness of the vaccine.

Reader View: People don’t have too many options but to trust a quickly-made Covid vaccine

YourTurn is our new weekly feature in which ThePrint's readers share their views or opinions in response to the question of the week.

On Camera

If fundamental right to property can be taken away, so can all the others: AG Mulgaokar

If this step even partially achieves its desired results, there will be so much dislocation in the country’s economic structure as to prove a national calamity, advocate AG Mulgaokar wrote in 1969.

Niti Aayog recommends fully decriminalising 12 offences under new I-T Act to ‘foster more trust’

Recommendations appear in Niti Aayog’s Tax Policy Working Paper Series–II. It says there is a need to shift away from fear-based enforcement to trust-based governance.

India, UK sign £350 mn deal for Martlet. What are these Lightweight Multirole Missiles

In service with the British military since 2019, it is also known as the Martlet missile. Ukrainians have also deployed these missiles against Russian troops.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.